Amgen holder plans sale of 2,970 common shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Amgen Inc. has a filing covering a planned sale of up to 2,970 shares of common stock through Raymond James & Associates on or after 08/06/2026 on NASDAQ. The shares derive from cashless stock option exercises dated 04/27/2018 for 1,970 shares and 05/03/2019 for 1,000 shares. The Securities Information section also lists a related figure of 1,193,940.00 alongside the 2,970 shares.
Key Figures
Key Terms
Cashless Stock Option Exercise financial
Securities Information financial
Securities To Be Sold financial
Securities Sold During The Past 3 Months financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the Amgen (AMGN) Form 144/A filing describe?
AI-generated analysis. How Rhea-AI works. Not financial advice.